Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Prytz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|January 1, 1990
Differential cell cycle perturbation by transmethylation inhibitorsP S Prytz, J Aarbakke
Cytometry|June 1, 1995
A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNAP C Endresen, P S Prytz, J Aarbakke
Therapeutic Drug Monitoring|January 1, 1986
Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatographyL Slørdal, P S Prytz, I Pettersen, et al.
Pharmacology & Toxicology|May 1, 1987
High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesisU Aasebø, L Slørdal, P S Prytz, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosineP C Endresen, P S Prytz, S Lysne, et al.
Pediatric Hematology and Oncology|January 1, 1987
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokineticsL Slørdal, S Kolmannskog, P J Moe, et al.
Pediatric Hematology and Oncology|January 1, 1986
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapyL Slørdal, S Kolmannskog, P S Prytz, et al.
Biochemical Pharmacology|October 9, 1991
Elevation of cyclic AMP levels in HL-60 cells accumulated in G1 or G2 by transmethylation inhibitorsP S Prytz, B E Bang, P C Endresen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1988
Catecholamine binding and concentrations in acute phase plasma after surgeryG Sager, T Trovik, L Slørdal, et al.
Cancer Research|November 1, 1986
Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolaseJ Aarbakke, G A Miura, P S Prytz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|January 1, 1990
Differential cell cycle perturbation by transmethylation inhibitorsP S Prytz, J Aarbakke
Cytometry|June 1, 1995
A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNAP C Endresen, P S Prytz, J Aarbakke
Therapeutic Drug Monitoring|January 1, 1986
Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatographyL Slørdal, P S Prytz, I Pettersen, et al.
Pharmacology & Toxicology|May 1, 1987
High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesisU Aasebø, L Slørdal, P S Prytz, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosineP C Endresen, P S Prytz, S Lysne, et al.
Pediatric Hematology and Oncology|January 1, 1987
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokineticsL Slørdal, S Kolmannskog, P J Moe, et al.
Pediatric Hematology and Oncology|January 1, 1986
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapyL Slørdal, S Kolmannskog, P S Prytz, et al.
Biochemical Pharmacology|October 9, 1991
Elevation of cyclic AMP levels in HL-60 cells accumulated in G1 or G2 by transmethylation inhibitorsP S Prytz, B E Bang, P C Endresen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1988
Catecholamine binding and concentrations in acute phase plasma after surgeryG Sager, T Trovik, L Slørdal, et al.
Cancer Research|November 1, 1986
Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolaseJ Aarbakke, G A Miura, P S Prytz, et al.
Pageof 2